Original ResearchPublished 9 October 2026Tirzepatide versus other glucose-lowering therapies and risk of COPD exacerbations in patients with comorbid type 2 diabetes: a retrospective cohort studyWan-Hsuan Hsu · Yang-En Chan · Jheng-Yan Wu · Yao-Ming Chuang · Chia-Yu Kuo · Bo-Wen Shiau · Po-Yu Huang · Chih-Cheng LaiFrontiers in Pharmacologydoi 10.3389/fphar.2026.1917340